Population analysis of Legionella pneumophila reveals the basis of resistance to complement-mediated killing

Bryan A. Wee, Joana Alves, Diane Lindsay, Ross Cameron, Amy C. Pickering, Jamie Gorzynski, Jukka Corander, Pekka Marttinen, Andrew Smith, J. Ross FitzgeraldbioRxiv 2020 · DOI

Introduction

Legionella pneumophila is a Gram-negative bacterium typically found in freshwater environments, where it exists as an intracellular symbiont of free-living amoebae. However, when aerosolized and inhaled by humans—often via contaminated cooling towers or complex plumbing systems—it can cause Legionnaires’ disease, a severe and potentially fatal pneumonia. For over 30 years, a central mystery in the field has been why certain strains of L. pneumophila are highly resistant to being killed by human serum (the liquid component of blood containing immune proteins), while others are easily destroyed. This study utilizes large-scale genomics to identify the genetic "smoking gun" behind this immune evasion.

Genomic Mapping of Pathogenicity

To identify the bacterial factors driving human pathogenicity, researchers conducted a population genomic study of 900 L. pneumophila isolates. This robust dataset included 400 newly sequenced isolates from the Scottish Microbiology Reference Laboratory (collected between 1984 and 2015) and 500 publicly available genomes to provide global context.

The team employed a Genome-Wide Association Study (GWAS) to compare clinical (disease-causing) and environmental isolates. Using two distinct methodologies—SEER (which analyzes short DNA sequences called k-mers) and SCOARY (which focuses on known orthologous genes)—they screened over 11,000 accessory genes. The analysis identified a single gene, lag-1, as the factor most significantly associated with clinical isolates (p-value: 9.74E-11).

The Role of lag-1 and Horizontal Gene Transfer

The lag-1 gene encodes an O-acetyltransferase, an enzyme responsible for modifying the lipopolysaccharide (LPS) on the bacterial surface by adding a specific acetyl group. Molecular evolutionary analysis, including split network and phylogenetic tree construction, revealed that lag-1 is not restricted to a single branch of the Legionella family tree. Instead, it has been distributed across all major phylogenetic clades through frequent and recent horizontal gene transfer (recombination). This indicates that environmental strains can acquire the capacity for human disease by obtaining this specific gene cluster from other strains.

Mechanism: Cloaking from the Complement System

Functional validation confirmed that the presence of lag-1 directly correlates with the bacteria's ability to survive the human immune onslaught. By performing "knock-in" experiments, the researchers demonstrated that adding lag-1 to previously susceptible strains conferred several key advantages:

  • Serum and Lung Fluid Resistance: Strains with a functional lag-1 gene showed enhanced survival in both human plasma and bovine broncho-alveolar lavage (BAL) fluid.
  • Neutrophil Evasion: In phagocytosis assays, lag-1 positive strains showed significantly lower internalization by human neutrophils compared to strains lacking the gene.

The study pinpointed the exact mechanism: lag-1 specifically inhibits the classical complement pathway. By modifying the LPS, the bacteria prevent C3 proteins—the immune system's "tags"—from depositing on their surface. Without these tags, the bacteria remain effectively invisible to the immune system, allowing them to avoid being swallowed by white blood cells or lysed by immune proteins.

Conclusion and Future Directions

This research solves a long-standing mystery regarding L. pneumophila serum resistance, identifying lag-1 as a primary determinant of human pathogenicity. While the authors note that lag-1 is likely not the only factor involved—as some clinical isolates lack the gene—it represents a major mechanism of immune evasion. Future work may explore the evolutionary costs of maintaining lag-1 in nutrient-poor environmental water and whether targeting the lag-1 enzyme could provide a new therapeutic pathway to "unmask" the bacteria, making them visible to the patient's immune system once again.

Summary updated

Abstract

Abstract Legionella pneumophila is the most common cause of the severe respiratory infection known as Legionnaires’ disease. L. pneumophila is typically a symbiont of free-living amoeba, and our understanding of the bacterial factors that determine human pathogenicity is limited. Here we carried out a population genomic study of 900 L. pneumophila isolates from human clinical and environmental samples to examine their genetic diversity, global distribution and the basis for human pathogenicity. We found that although some clones are more commonly associated with clinical infections, the capacity for human disease is representative of the breadth of species diversity. To investigate the bacterial genetic basis for human disease potential, we carried out a genome-wide association study that identified a single gene ( lag-1 ), to be most strongly associated with clinical isolates. Molecular evolutionary analysis showed that lag-1 , which encodes an O -acetyltransferase responsible for lipopolysaccharide modification, has been distributed horizontally across all major phylogenetic clades of L. pneumophila by frequent recent recombination events. Functional analysis revealed a correlation between the presence of a functional lag-1 gene and resistance to killing in human serum and bovine broncho-alveolar lavage. In addition, L. pneumophila strains that express lag-1 escaped complement-mediated phagocytosis by neutrophils. Importantly, we discovered that the expression of lag-1 confers the capacity to evade complement-mediated killing by inhibiting deposition of classical pathway molecules on the bacterial surface. In summary, our combined population and functional analyses identified L. pneumophila genetic traits linked to human disease and revealed the molecular basis for resistance to complement-mediated killing, a previously elusive trait of direct relevance to human disease pathogenicity. Significance Legionella pneumophila is an environmental bacterium associated with a severe pneumonia known as Legionnaires’ disease. A small number of L. pneumophila clones are responsible for a large proportion of human infections suggesting they have enhanced pathogenicity. Here, we employed a large-scale population analysis to investigate the evolution of human pathogenicity and identified a single gene ( lag-1 ) that was more frequently found in clinical isolates. Functional analysis revealed that the lag-1 -encoded O -acetyltransferase, involved in modification of lipopolysaccharide, conferred resistance to the classical pathway of complement in human serum. These findings solve a long-standing mystery in the field regarding L. pneumophila resistance to serum killing, revealing a novel mechanism by which L. pneumophila may avoid immune defences during infection.
BibTeX
@misc{wee2020population,
  author = {Bryan A. Wee and Joana Alves and Diane Lindsay and Ross Cameron and Amy C. Pickering and Jamie Gorzynski and Jukka Corander and Pekka Marttinen and Andrew Smith and J. Ross Fitzgerald},
  title = {{Population analysis of <i>Legionella pneumophila</i> reveals the basis of resistance to complement-mediated killing}},
  year = {2020},
  doi = {10.1101/2020.08.14.250670},
  howpublished = {bioRxiv},
}
Figure